| Name | Title | Contact Details |
|---|
Founded in 1924 by philanthropist Ellen Browning Scripps, Scripps is a non-profit integrated health care delivery system based in San Diego, Calif. We treat more than 700,000 patients annually through the dedication of 3,000 affiliated physicians and more than 15,000 employees among our five acute-care hospital campuses, hospice and home health care services, 27 outpatient centers and clinics, and hundreds of affiliated physician offices throughout the region. Medical Excellence Every Step of the Way Recognized as a leader in disease and injury prevention, diagnosis and treatment, Scripps has been ranked four times as one of the nation`s best health care systems by Truven Health Analytics. Our hospitals are consistently ranked by U.S. News & World Report among the nation`s best – and Scripps is regularly recognized by Fortune, Working Mother magazine and The Advisory Board as one of the best places in the nation to work. Scripps is also at the forefront of clinical research, genomic medicine and wireless health care. With three highly respected graduate medical education programs, Scripps is a longstanding member of the Association of American Medical Colleges.
Draeger Safety Pacific is a supplier of high quality respiratory protection, including single and dual filter masks as well as different material options to suit all customer requirements.
ChiroCode Institute is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
At PanOptica, our aim is to develop new ocular therapies that help patients see their very best throughout their lives. Many patients with common eye diseases suffer debilitating vision loss, despite currently available treatments. At PanOptica, we understand the critical role vision plays in a patient`s quality of life. And we know the frustration eye care professionals face when they are unable to treat their patients successfully. Today, significant progress is being made in the field of ophthalmology, with small laboratories and large pharmaceutical companies alike exploring newer, more effective treatments for sight-threatening diseases. PanOptica seeks to license and develop these innovative therapeutics, which may include improvements to existing therapies or entirely new treatments for previously untreatable disorders. Our lead development compound, PAN-90806 , is a novel, small-molecule selective VEGF receptor antagonist that shows promise as a topical treatment for wet age-related macular degeneration and diabetic retinopathy.
Bird Products Corporation is a Palm Springs, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.